Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company based in California, focused on developing therapeutics that modulate lipid-signaling pathways, particularly the endocannabinoid system. Its key products include ART27.13 for cancer-related anorexia and ART26.12 for chemotherapy-induced peripheral neuropathy. With significant market opportunities exceeding $2 billion for cancer anorexia and over $1 billion for neuropathy, Artelo is advancing innovative therapies through clinical trials and strategic partnerships.
This description was generated via AI from an annual report. Updated about 1 year ago.